(1R,2R,4R,5R,7S,10R,11S,14S,16S,18S,19S)-5,7-Dihydroxy-10,14-dimethylhexacyclo[9.8.0.02,4.05,10.014,19.016,18]nonadecan-15-one
3-Deoxo-4,5-Dihydro-5beta-Hydroxy Drospirenone is listed by Simson Pharma as a impurity standards for laboratory research, analytical development and quality-control workflows.
Suitability is method- and purpose-specific. Before use, verify the product name, catalogue number, chemical identifiers, storage requirements and the information reported in the current product or batch documentation. Your laboratory remains responsible for method qualification or validation.
3-Deoxo-4,5-Dihydro-5beta-Hydroxy Drospirenone for method validation 3-Deoxo-4,5-Dihydro-5beta-Hydroxy Drospirenone reference standard 3-Deoxo-4,5-Dihydro-5beta-Hydroxy Drospirenone for ANDA filing 3-Deoxo-4,5-Dihydro-5beta-Hydroxy Drospirenone for forced degradation studies 3-Deoxo-4,5-Dihydro-5beta-Hydroxy Drospirenone identification standard 3-Deoxo-4,5-Dihydro-5beta-Hydroxy Drospirenone for DMF filing 3-Deoxo-4,5-Dihydro-5beta-Hydroxy Drospirenone HPLC standard 3-Deoxo-4,5-Dihydro-5beta-Hydroxy Drospirenone supplier 3-Deoxo-4,5-Dihydro-5beta-Hydroxy Drospirenone manufacturer 3-Deoxo-4,5-Dihydro-5beta-Hydroxy Drospirenone distributor
